Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objectives
Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subjective cognitive decline (SCD), amnestic (aMCI), an...
Alternative Titles
Full title
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5607543
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5607543
Other Identifiers
ISSN
2162-3279
E-ISSN
2162-3279
DOI
10.1002/brb3.776
